These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

900 related items for PubMed ID: 15004758

  • 21. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, Cillo U, Zanus G, Fagiuoli S, Rugge M.
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [Abstract] [Full Text] [Related]

  • 22. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 23. Development and validation of a model predicting graft survival after liver transplantation.
    Ioannou GN.
    Liver Transpl; 2006 Nov 15; 12(11):1594-606. PubMed ID: 16952176
    [Abstract] [Full Text] [Related]

  • 24. An analysis of liver transplant survival rates from the UNOS registry.
    Goh A.
    Clin Transpl; 2008 Nov 15; ():19-34. PubMed ID: 19711511
    [Abstract] [Full Text] [Related]

  • 25. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct 15; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 26. Predictors of patient and graft survival following liver transplantation for hepatitis C.
    Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, Hoofnagle J.
    Hepatology; 1998 Sep 15; 28(3):823-30. PubMed ID: 9731579
    [Abstract] [Full Text] [Related]

  • 27. Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.
    Chavalitdhamrong D, Gill J, Takemoto S, Madhira BR, Cho YW, Shah T, Bunnapradist S.
    Transplantation; 2008 Jun 15; 85(11):1573-9. PubMed ID: 18551062
    [Abstract] [Full Text] [Related]

  • 28. Twenty cases of adult-to-adult living-related liver transplantation: single-center experience in Saudi Arabia.
    Abdullah K, Abdeldayem H, Hali WO, Sakran A, Yassen K, Abdulkareem A.
    Transplant Proc; 2005 Sep 15; 37(7):3144-6. PubMed ID: 16213331
    [Abstract] [Full Text] [Related]

  • 29. Is recurrent hepatitis C worse with living donors?
    Kuo A, Terrault NA.
    Curr Opin Organ Transplant; 2009 Jun 15; 14(3):240-4. PubMed ID: 19395968
    [Abstract] [Full Text] [Related]

  • 30. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.
    Liver Transpl; 2008 Dec 15; 14(12):1778-86. PubMed ID: 19025914
    [Abstract] [Full Text] [Related]

  • 31. Advanced donor age alone does not affect patient or graft survival after liver transplantation.
    Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC.
    J Am Coll Surg; 2008 Dec 15; 207(6):847-52. PubMed ID: 19183530
    [Abstract] [Full Text] [Related]

  • 32. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
    Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.
    Transplant Proc; 2007 Dec 15; 39(10):3261-5. PubMed ID: 18089367
    [Abstract] [Full Text] [Related]

  • 33. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers.
    Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, Edwards E, Taranto S, Johnson LB.
    Liver Transpl; 2001 Sep 15; 7(9):762-8. PubMed ID: 11552208
    [Abstract] [Full Text] [Related]

  • 34. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA.
    Liver Transpl; 2004 Oct 15; 10(10):1248-55. PubMed ID: 15376308
    [Abstract] [Full Text] [Related]

  • 35. Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
    Thuluvath PJ, Krok KL, Segev DL, Yoo HY.
    Liver Transpl; 2007 May 15; 13(5):719-24. PubMed ID: 17457933
    [Abstract] [Full Text] [Related]

  • 36. Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Bozorgzadeh A.
    Transplant Proc; 2005 Sep 15; 37(7):3162-4. PubMed ID: 16213337
    [Abstract] [Full Text] [Related]

  • 37. Living donor liver transplantation for children with liver failure and concurrent multiple organ system failure.
    Mack CL, Ferrario M, Abecassis M, Whitington PF, Superina RA, Alonso EM.
    Liver Transpl; 2001 Oct 15; 7(10):890-5. PubMed ID: 11679988
    [Abstract] [Full Text] [Related]

  • 38. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 15; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 39. Impact of donor age and recipient status on left-lobe graft for living donor adult liver transplantation.
    Yoshizumi T, Taketomi A, Soejima Y, Uchiyama H, Ikegami T, Harada N, Kayashima H, Yamashita Y, Shimada M, Maehara Y.
    Transpl Int; 2008 Jan 15; 21(1):81-8. PubMed ID: 17887958
    [Abstract] [Full Text] [Related]

  • 40. Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression.
    Toniutto P, Minisini R, Fabris C, De Feo T, Marangoni F, Burlone M, Avellini C, Bitetto D, Fornasiere E, Fumolo E, Baccarani U, Pirisi M.
    Clin Transplant; 2009 Jan 15; 23(2):184-90. PubMed ID: 19210526
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.